Literature DB >> 7880930

Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura.

C Schiavotto1, M Ruggeri, F Rodeghiero.   

Abstract

Repeated courses of HD IVIg are reported to induce stable remission in a significant proportion of adults with chronic refractory ITP. We have treated 14 such patients obtaining a remission rate quite comparable to the 5-10% of spontaneous remission.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7880930     DOI： 10.1007/bf01834386

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  5 in total

Review 1.  Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: review of the literature.

Authors:  J B Bussel; L C Pham
Journal:  Vox Sang       Date:  1987       Impact factor: 2.144

2.  Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin.

Authors:  B Godeau; S Lesage; M Divine; V Wirquin; J P Farcet; P Bierling
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

Review 3.  Therapy of chronic idiopathic thrombocytopenic purpura in adults.

Authors:  P Berchtold; R McMillan
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

4.  Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.

Authors:  C Schiavotto; F Rodeghiero
Journal:  Haematologica       Date:  1993 Nov-Dec       Impact factor: 9.941

5.  Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin.

Authors:  J B Bussel; L C Pham; L Aledort; R Nachman
Journal:  Blood       Date:  1988-07       Impact factor: 22.113
  5 in total
  2 in total

Review 1.  [Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].

Authors:  A Böcher; F G Hagmann; H Kreiter
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.